1Orley J,Kuyken W.Eds.Quality of life Assessment:International Perspectives.Springer Verlag Heidelberg:1994.
2WHOQOL Group.Development of the WHOQOL:rationale and current status.Int J Mental Health,1994,23:24-56.
3WHOQOL Group.The World Health Organization Quality of Life assessment(WHOQOL):position paper from the World Health Organization.Soc Sci Med,1995,41:1403-1409.
4WHOQOL Group.The World Health Organization Quality of Life assessment(WHOQOL):development and general psychometric properties.Soc Sci Med,1998,46(12):1569-1585.
5rwick DM,Murphy JM,Goldman PA,et al.Performance on a five-item mental health screening test.Med Care,1991,29:169-176.
6WHOQOL Group.Development of the World Health Organization WHOQOL-BREF Quality of Life assessment.Psychol Med,1998,28:551-558.
7Power M,Bullinger M,Harper A,et al.The World Health Organization WHOQOL-100:Tests of the Universality of Quality of Life in 15 Different Cultural Groups Worldwide.Health Psychol,1999,18(5):495-505.
8Bollen KA.Structural Equations with Latent Variables.New York:John Wiley and Sons,1989.
9Cronbach LJ.Coefficient alpha and the internal structure of tests.Psychometrika,1951,16:297-334.
10The WHOQOL GROUP.Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment.Psychol Med,1998,28:551-558.
1N e grier S, Mercatello A, Coronel B, et al.Immunotherapy of metastatic kidney cancer.Prog Uroi,1993,3(2):187-194.
2Pert SL, Wand H, Law MG, et al. Evaluation of Subcutaneous Proleukin(interleukin-2)in a Randomized International Trial(ESPRIT): geographical and gender differences in the baseline characteristics of participants. HIV clinical trials,2006,7(2):70-85.
4Tyre C C, Quan W.Nursing care of patients receiving high-dose, continuous-infusion interleukin-2 with pulse dose and famotidine. Clin J Oncol Nurs,2007,11(4):513-519.
